Enhancing Breast Cancer Diagnosis through Predictive Analytics

Authors

  • Shruti Balla UG Students, Department of Computer Science and Engineering, SVERI’s College of Engineering, Pandharpur, Maharashtra, India Author
  • Suyesha Patil UG Students, Department of Computer Science and Engineering, SVERI’s College of Engineering, Pandharpur, Maharashtra, India Author
  • Vaishnavi Kashid UG Students, Department of Computer Science and Engineering, SVERI’s College of Engineering, Pandharpur, Maharashtra, India Author
  • Sandhya Kokate UG Students, Department of Computer Science and Engineering, SVERI’s College of Engineering, Pandharpur, Maharashtra, India Author
  • Ashwini Birajdar UG Students, Department of Computer Science and Engineering, SVERI’s Author
  • S. M. Shinde Assistant Professor, Department of Computer Science and Engineering, SVERI’s College of Engineering, Pandharpur, Maharashtra, India Author

DOI:

https://doi.org/10.32628/CSEIT241061133

Keywords:

breast cancer, artificial intelligence, machine learning, power BI

Abstract

Breast cancer is one of the leading causes of cancer-related deaths among women globally. Early and accurate diagnosis is crucial for improving patient outcomes. Predictive analytics, leveraging machine learning and artificial intelligence (AI), offers promising advancements in breast cancer diagnosis by enhancing diagnostic accuracy, reducing false positives, and enabling personalized treatment plans. This research explores the role of predictive analytics in breast cancer diagnosis, covering methodologies, benefits, challenges, and future directions. Creating a power BI dashboard for visualization. By analyzing data from various sources, including mammograms, biopsies, and genetic profiles, predictive models can significantly improve diagnostic precision, thus contributing to better healthcare delivery.

Downloads

Download data is not yet available.

References

Wilson N, Ironside A, Diana A, Oikonomidou O. Lobular breast Cancer: a review. Front Oncol 2021;10.https://pubmed.ncbi.nlm.nih.gov/335207 DOI: https://doi.org/10.3389/fonc.2020.591399

Oesterreich S, Nasrazadani A, Zou J, Carleton N, Onger T, Wright MD, et al. Clinicopathological features and outcomes comparing patients with invasive ductal and lobular breast Cancer. JNCI: J Natl Cancer Inst. 2022;114(11):1511–22.https://pubmed.ncbi.nlm.nih.gov/362397/ DOI: https://doi.org/10.1093/jnci/djac157

Yang C, Lei C, Zhang Y, Zhang J, Ji F, Pan W, et al. Comparison of overall survival between invasive lobular breast carcinoma and invasive ductal breast carcinoma: a propensity score matching study based on SEER Database

Engstrøm MJ, Opdahl S, Vatten LJ, Haugen OA, Bofin AM. Invasive lobular breast cancer: the prognostic impact of histopathological grade, E-cadherin and molecular subtypes. Histopathology

Giovanni Corso, Nicola Fusco, Elena Guerini-Rocco, Maria Cristina Leonardi, Carmen Criscitiello, Paola Zagami, Eleonora Nicolo, Giovanni Mazzarol.

El Ouardani S, Chibani H, El Jarroudi M, Mouhoub M, Al Jarroudi O, Hadj Kacem H, Brahmi SA, Afqir S. Diagnostic Challenges for Clinicians in Lobular

Koufopoulos N, Pateras IS, Gouloumis AR, Ieronimaki AI, Zacharatou A, Spathis A, Leventakou D, Economopoulou P, Psyrri A.

Jocelyn Luveta, Ruth M Parks, David M Heery. Lobular Breast Cancer as a Distinct Dise

Hind D, Ward S, De Nigris E, Simpson E, Carroll C.Hormonal therapies for early breast cancer

Christopher Dunn, Susan J Keam,Letrozole: a pharmacoeconomic women with breast cancer2006.https://pubmed.ncbi.nlm.nih.gov

Downloads

Published

27-11-2024

Issue

Section

Research Articles

Similar Articles

1-10 of 453

You may also start an advanced similarity search for this article.